Yüklüyor......
Radiation dermatitis in patients treated with concurrent trastuzumab emtansine (T-DM1)
Trastuzumab Emtansine (T-DM1) improves outcomes for patients with HER2+ breast cancer, and is given concurrently with radiation. We have noted increased radiation dermatitis in these patients, which may have been underreported on the KATHERINE clinical trial, and call for clinicians to remain vigila...
Kaydedildi:
| Yayımlandı: | Clin Transl Radiat Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369349/ https://ncbi.nlm.nih.gov/pubmed/32715108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2020.06.013 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|